Ubiquitous detection of gram-positive bacteria with bioorthogonal magnetofluorescent nanoparticles.

The ability to rapidly diagnose gram-positive pathogenic bacteria would have far reaching biomedical and technological applications. Here we describe the bioorthogonal modification of small molecule antibiotics (vancomycin and daptomycin), which bind to the cell wall of gram-positive bacteria. The bound antibiotics conjugates can be reacted orthogonally with tetrazine-modified nanoparticles, via an almost instantaneous cycloaddition, which subsequently renders the bacteria detectable by optical or magnetic sensing. We show that this approach is specific, selective, fast and biocompatible. Furthermore, it can be adapted to the detection of intracellular pathogens. Importantly, this strategy enables detection of entire classes of bacteria, a feat that is difficult to achieve using current antibody approaches. Compared to covalent nanoparticle conjugates, our bioorthogonal method demonstrated 1-2 orders of magnitude greater sensitivity. This bioorthogonal labeling method could ultimately be applied to a variety of other small molecules with specificity for infectious pathogens, enabling their detection and diagnosis.

[1]  David Issadore,et al.  Miniature magnetic resonance system for point-of-care diagnostics. , 2011, Lab on a chip.

[2]  Hakho Lee,et al.  Probing intracellular biomarkers and mediators of cell activation using nanosensors and bioorthogonal chemistry. , 2011, ACS nano.

[3]  Hakho Lee,et al.  Micro-NMR for Rapid Molecular Analysis of Human Tumor Samples , 2011, Science Translational Medicine.

[4]  Hakho Lee,et al.  Bioorthogonal chemistry amplifies nanoparticle binding and enhances the sensitivity of cell detection. , 2010, Nature nanotechnology.

[5]  Ying Liu,et al.  Rapid analysis of Gram-positive bacteria in water via membrane filtration coupled with nanoprobe-based MALDI-MS , 2010, Analytical and bioanalytical chemistry.

[6]  T. Silhavy,et al.  The bacterial cell envelope. , 2010, Cold Spring Harbor perspectives in biology.

[7]  S. Chakraborty,et al.  Nanoconjugated vancomycin: new opportunities for the development of anti-VRSA agents , 2010, Nanotechnology.

[8]  Chad A. Mirkin,et al.  Drivers of biodiagnostic development , 2009, Nature.

[9]  Ralph Weissleder,et al.  Fast and sensitive pretargeted labeling of cancer cells through a tetrazine/trans-cyclooctene cycloaddition. , 2009, Angewandte Chemie.

[10]  N. Woodford,et al.  Infections caused by Gram-positive bacteria: a review of the global challenge. , 2009, The Journal of infection.

[11]  Hakho Lee,et al.  Rapid detection and profiling of cancer cells in fine-needle aspirates , 2009, Proceedings of the National Academy of Sciences.

[12]  Hakho Lee,et al.  Ultrasensitive detection of bacteria using core-shell nanoparticles and an NMR-filter system. , 2009, Angewandte Chemie.

[13]  Donhee Ham,et al.  Chip–NMR biosensor for detection and molecular analysis of cells , 2008, Nature Medicine.

[14]  Kate E. Jones,et al.  Global trends in emerging infectious diseases , 2008, Nature.

[15]  Yu-Chie Chen,et al.  Functional gold nanoparticles as photothermal agents for selective-killing of pathogenic bacteria. , 2007, Nanomedicine.

[16]  W. Scott,et al.  NMR structural studies of the antibiotic lipopeptide daptomycin in DHPC micelles. , 2007, Biochimica et biophysica acta.

[17]  F. Tally,et al.  Daptomycin: a lipopeptide antibiotic for the treatment of serious Gram-positive infections. , 2005, The Journal of antimicrobial chemotherapy.

[18]  Yu-Chie Chen,et al.  Affinity capture using vancomycin-bound magnetic nanoparticles for the MALDI-MS analysis of bacteria. , 2005, Analytical chemistry.

[19]  P. Reynolds Structure, biochemistry and mechanism of action of glycopeptide antibiotics , 1989, European Journal of Clinical Microbiology and Infectious Diseases.

[20]  F. Menichetti Current and emerging serious Gram-positive infections. , 2005, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[21]  R. Hancock,et al.  Structural transitions as determinants of the action of the calcium-dependent antibiotic daptomycin. , 2004, Chemistry & biology.

[22]  Bing Xu,et al.  Using biofunctional magnetic nanoparticles to capture vancomycin-resistant enterococci and other gram-positive bacteria at ultralow concentration. , 2003, Journal of the American Chemical Society.

[23]  C. Abell,et al.  Binding of vancomycin group antibiotics to D-alanine and D-lactate presenting self-assembled monolayers. , 2000, Bioorganic & medicinal chemistry.

[24]  Michael J. Rybak,et al.  In Vitro Activities of Daptomycin, Vancomycin, Linezolid, and Quinupristin-Dalfopristin against Staphylococci and Enterococci, Including Vancomycin- Intermediate and -Resistant Strains , 2000, Antimicrobial Agents and Chemotherapy.

[25]  George M. Whitesides,et al.  Using Surface Plasmon Resonance to Study the Binding of Vancomycin and Its Dimer to Self-Assembled Monolayers Presenting d-Ala-d-Ala , 1999 .

[26]  R Weissleder,et al.  High-efficiency intracellular magnetic labeling with novel superparamagnetic-Tat peptide conjugates. , 1999, Bioconjugate chemistry.

[27]  R. Nagarajan,et al.  Antibacterial activities and modes of action of vancomycin and related glycopeptides , 1991, Antimicrobial Agents and Chemotherapy.